aarti drugs

[Stock idea] – Aarti Drugs…notes for a leading pharma API company

Hello Sir,Hope you are doing well.Remember, in late 2020, Pharma API companies were the darling of the market. Most are down 50-60% from their highs and in downtrend. Their high margins of FY 20-21 didn’t sustain.It seems like earnings may have bottomed out and some of them seem to be available at reasonable valuations from a 3-4 years investment perspective.Aarti Drugs is a major player in the pharma API segment and has been a very lucky stock for us.We have recommended…

Read More

[Stock Idea] – Aarti Drugs…notes from the Q1 FY 23 concall

Hello Sir,Hope you are doing well.Remember, in late 2020, Pharma API companies were the darling of the market. Most are down 40-50% from their highs and in downtrend. Their high margins of FY 20-21 didn’t sustain. Some of them will soon be available at reasonable valuations on long term mean margins and that will be a good time to invest.Aarti Drugs is a major player in the pharma API segment and has been a very lucky stock for us. We recommended…

Read More

Aarti – 5x in 2.5 years…Coverage closure update

Dear Sir, In Sep’18 we initiated coverage on Aarti, leading API manufacturer, for our Premium Members. You can read the detailed initiation report on the company at the following LINK Recently, on 5th Feb’21, we finally closed the coverage on the stock and booked complete profit in our Model Sheets as well. The company has been a great wealth creator for us and our members. We first initiated coverage on the same in Feb’14 around 27-28 odd levels (adjusted for…

Read More
Copy Protected by Chetan's WP-Copyprotect.